-transparent.png){kind=logo}
A new anti-arrhythmic agent, lorcainide, has been compared with lignocaine in patients with acute myocardial infarction. Lorcainide has been shown to be as effective as lignocaine in suppressing ventricular ectopy. Lorcainide is unusually free of side-effects and has the great advantage over lignocaine of being effective when given orally.
Related Publications
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
February 1980,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
July 1963,
Current therapeutic research, clinical and experimental,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
September 1980,
Revista clinica espanola,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
March 1987,
Ugeskrift for laeger,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
December 1977,
Archives internationales de pharmacodynamie et de therapie,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
April 1980,
Minerva medica,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
February 1972,
Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
November 2000,
Expert opinion on investigational drugs,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
March 1972,
Lakartidningen,
E A Lloyd, and
L J Workman, and
P J Commerford, and
T A Mabin
October 1989,
Cardiovascular research,
